Abstract
Using a unique surgical model (the donor rat model), we showed previously that duodenal replacement of bile-pancreatic juice, obtained fresh from a donor rat, ameliorates ligation-induced acute pancreatitis. We hypothesize that bile-pancreatic juice exclusion from gut exacerbates Akt/nuclear factor-kB (NF-kB) pathway activation and induces chemokine production in ligation-induced acute pancreatitis. We compared rats with bile-pancreatic duct ligation to those with duodenal bile-pancreatic juice replacement fresh from a donor rat beginning immediately before duct ligation. Sham control rats had ducts dissected but not ligated. Rats were killed 1 or 3 hours after operation (n=7/group). Akt activation (immunoblotting, immune-complex kinase assay, and ELISA), inhibitory protein I-kB (I-kB) activation (immunoblotting), and production of chemokines MCP-1 and RANTES (ELISA) were measured in pancreatic homogenates. NF-kB was quantitated in nuclear fractions using electrophoretic mobility shift assay. Duct ligation produced significant increases in pancreatic Akt, IkB, and NF-kB activation and production of MCP-1 and RANTES. Activation of the Akt/NF-kB pathway and increased MCP-1 and RANTES production in response to duct ligation were significantly reduced by bile-pancreatic juice replacement (ANOVA, P<0.05). Bile-pancreatic juice exclusion stimulates Akt/NF-kB pathway activation and increases chemokine production in ligation-induced acute pancreatitis.
Similar content being viewed by others
References
Samuel I, Toriumi Y, Wilcockson DP, Turkelson CM, Solomon TE, Joehl RJ. Bile and pancreatic juice replacement ameliorates early ligation-induced acute pancreatitis in rats. Am J Surg 1995;169:391–399.
Samuel I, Toriumi Y, Zaheer A, Joehl RJ. Mechanism of acute pancreatitis exacerbation by enteral bile-pancreatic juice exclusion. Pancreatology 2004;4:527–532.
Samuel I, Zaheer S, Zaheer A. Bile-pancreatic juice exclusion increases p38MAPK activation and TNF-alpha production in ligation-induced acute pancreatitis in rats. Pancreatology 2005;5:20–26.
Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, Silengo L, Sozzani S, Mantovani A, Altruda F, Wymann MP. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 2000;287(5455):1049–1053.
Strassheim D, Asehnoune K, Park JS, Kim JY, He Q, Richter D, Kuhn K, Mitra S, Abraham E. Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of Toll-like receptor 2-stimulated neutrophils. J Immunol 2004;172:5727–5733.
Tas SW, Remans PH, Reedquist KA, Tak PP. Signal transduction pathways and transcription factors as therapeutic targets in inflammatory disease: Towards innovative antirheumatic therapy. Curr Pharm Des 2005;11:581–611.
Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002;109(Suppl):S81-S96.
Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005;9:59–71.
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999;401(6748):82–85.
Samuel I, Joehl RJ. Bile-pancreatic juice replacement, not cholinergic and cholecystokinin-receptor blockade, reverses acinar cell hyperstimulation after bile-pancreatic duct ligation. Am J Surg 1996;171:207–211.
Kaplan R, Zaheer A, Jaye M, Lim R. Molecular cloning and expression of biologically active human glia maturation factor-beta. J Neurochem 1991;57:483–490.
Zaheer A, Lim R. In vitro inhibition of MAP kinase (ERK1/ERK2) activity by phosphorylated glia maturation factor (GMF). Biochemistry 1996;35:6283–6288.
Zaheer A, Yorek MA, Lim R. Effects of glia maturation factor overexpression in primary astrocytes on MAP kinase activation, transcription factor activation, and neurotrophin secretion. Neurochem Res 2001;26:1293–1299.
Samuel I, Zaheer S, Nelson JJ, Yorek MA, Zaheer A. CCK-A receptor induction and P38 and NF-kappaB activation in acute pancreatitis. Pancreatology 2004;4:49–56.
Bhatia M, Ramnath RD, Chevali L, Guglielmotti A. Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2005;288:G1259-G1265.
Bhatia M. Inflammatory response on the pancreatic acinar cell injury. Scand J Surg 2005;94:97–102.
Osman MO, Gesser B, Mortensen JT, Matsushima K, Jensen SL, Larsen CG. Profiles of pro-inflammatory cytokines in the serum of rabbits after experimentally induced acute pancreatitis. Cytokine 2002;17:53–59.
Rau B, Baumgart K, Kruger CM, Schilling M, Beger HG. CC-chemokine activation in acute pancreatitis: Enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications. Intensive Care Med 2003;29:622–629.
Dib M, Zhao X, Wang X, Andersson E, Drewsen G, Andersson R. Acute phase response in acute pancreatitis: A comparison with abdominal sepsis. Scand J Gastroenterol 2003;38:1072–1077.
Saluja AK, Steer MLP. Pathophysiology of pancreatitis. Role of cytokines and other mediators of inflammation. Digestion 1999;60(Suppl 1):27–33.
Ranson J, Rifkind K, Roses DF, Fink S, Eng K, Spencer F. Prognostic signs and the role of operative management in acute pancreatitis. Surgery 1974;139(Gynecol Obstetr):69–81.
Ranson J. Etiological and prognostic factors in human acute pancreatitis: A review. Am J Gastroenterol 1982;77:633–638.
Ohshio G, Saluja A, Steer ML. Effects of short-term pancreatic duct obstruction in rats. Gastroenterology 1991;104:1768–1779.
Samuel I, Toriumi Y, Yokoo H, Wilcockson DP, Trout JJ, Joehl RJ. Ligation-induced acute pancreatitis in rats and opossums: A comparative morphologic study of the early phase. J Surg Res 1994;57:1–13.
Steer ML. Workshop on experimental pancreatitis. Dig Dis Sci 1985;30:575–581.
Williams JA. Intracellular signaling mechanisms activated by cholecystokinin- regulating synthesis and secretion of digestive enzymes in pancreatic acinar cells. Annu Rev Physiol 2001;63:77–97.
Venter JC. The structure and evolution of adrenergic and muscarinic cholinergic receptors. J Cardiovasc Pharmacol 1987;10(Suppl 12):S69-S73.
Filippa N, Sable CL, Filloux C, Hemmings B, Van OE. Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase. Mol Cell Biol 1999;19:4989–5000.
Konishi H, Matsuzaki H, Tanaka M, Takemura Y, Kuroda S, Ono Y, Kikkawa U. Activation of protein kinase B (Akt/RAC-protein kinase) by cellular stress and its association with heat shock protein Hsp27. FEBS Lett 1997;410(2–3):493–498.
Madrid LV, Mayo MW, Reuther JY, Baldwin AS Jr. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 2001;276:18934–18940.
Chen X, Ji B, Han B, Ernst SA, Simeone D, Logsdon CD. NF-kappaB activation in pancreas induces pancreatic and systemic inflammatory response. Gastroenterology 2002;122:448–457.
Singh VP, Saluja AK, Bhagat L, van Acker GJ, Song AM, Soltoff SP, Cantley LC, Steer ML. Phosphatidylinositol 3-kinase-dependent activation of trypsinogen modulates the severity of acute pancreatitis. J Clin Invest 2001;108:1387–1395.
Moule SK, Welsh GI, Edgell NJ, Foulstone EJ, Proud CG, Denton RM. Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and beta-adrenergic agonists in rat epididymal fat cells. Activation of protein kinase B by wortmannin-sensitive and -insensitive mechanisms. J Biol Chem 1997;272:7713–7719.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Samuel, I., Yorek, M.A., Zaheer, A. et al. Bile-pancreatic juice exclusion promotes Akt/NF-kB activation and chemokine production in ligation-induced acute pancreatitis. J Gastrointest Surg 10, 950–959 (2006). https://doi.org/10.1016/j.gassur.2006.04.007
Issue Date:
DOI: https://doi.org/10.1016/j.gassur.2006.04.007